Trump science advisor says Chinese actors are copying American AI at massive scale

The framing here is notable for what it implies about policy direction rather than what it proves: calling this 'industrial scale' distillation without releasing the underlying evidence is the administration staking out a posture, not presenting a case. The practical question is whether this rhetoric precedes concrete export controls, compute restrictions, or new compliance burdens on frontier labs.

This connects directly to the TechCrunch piece from April 18 on Anthropic's thawing relationship with the Trump administration, which noted Anthropic had already been flagged as a supply-chain risk by the Pentagon. That story suggested the administration was beginning to treat frontier AI labs as strategic assets requiring vetting rather than purely commercial entities. This new signal from a Trump science advisor extends that logic outward: if domestic labs are supply-chain risks, foreign distillation of their outputs is a national security problem, not just an IP one. The two stories together suggest the administration is building a coherent, if still loosely defined, framework for AI as a controlled technology.

Watch whether the Commerce Department follows this rhetoric with additions to the Entity List or new model-weight export restrictions within the next 60 days. If it does, frontier labs will face compliance decisions that could reshape how they release weights and who they partner with internationally.